Zurcher Kantonalbank (Zurich Cantonalbank)
BankPosition in SCLX — Scilex Holding Co
CIK 1368163
ZURICH, V8
Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$293
-$243 QoQ
Shares Held
44
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Zurcher Kantonalbank (Zurich Cantonalbank) holds $2,249,447,823 across 14 Drug Manufacturers - General names. SCLX ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
638,306 | $587,094,709 | |
| 2 | AZN |
Astrazeneca PLC
|
1,992,762 | $393,012,521 | |
| 3 | JNJ |
Johnson & Johnson
|
1,559,955 | $381,315,400 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,624,637 | $226,425,658 | |
| 5 | ABBV |
AbbVie Inc.
|
660,576 | $143,668,674 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,024,300 | $123,213,047 | |
| 7 | PFE |
Pfizer Inc
|
3,805,542 | $106,859,619 | |
| 8 | AMGN |
Amgen Inc
|
282,696 | $99,466,587 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $293 | 44 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $536 | 44 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $865 | 44 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $259 | 44 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||